Further bolstering this hypothesis, a recent clinical study compared the ASD phenotype across three RASopathies, NF1, Noonan syndrome and cardiofaciocutaneous syndrome (CFC), which each stem from mutations in different regulators of the RAS-MAPK pathway. Here, NF1 is linked to cardiofaciocutaneous syndrome.